These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 644652)

  • 1. Distribution in isolated brain components of antigens combining with thymocytotoxins in New Zealand mice.
    Harbeck R; Hoffman AA; Hoffman SA
    Transplantation; 1978 Mar; 25(3):161-3. PubMed ID: 644652
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural cytotoxic autoantibody against thymocytes in NZB mice.
    Shirai T; Mellors RC
    Clin Exp Immunol; 1972 Sep; 12(1):133-52. PubMed ID: 4538858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic function in NZB mice. V. Decreased NK activity in NZB mice treated with a circulating thymic factor.
    Bardos P; Lebranchu Y; Bach MA
    Clin Immunol Immunopathol; 1982 Jun; 23(3):570-6. PubMed ID: 6889479
    [No Abstract]   [Full Text] [Related]  

  • 4. A peripheral and central T cell antigen recognized by a monoclonal thymocytotoxic autoantibody from New Zealand black mice.
    Surh CD; Gershwin ME; Ahmed A
    J Immunol; 1987 Mar; 138(5):1421-8. PubMed ID: 3543129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Function of thymic reticuloepithelial cells in New Zealand mice (II) (author's transl)].
    Minoda M; Nishida M; Horiuchi A
    Arerugi; 1981 May; 30(5):252-8. PubMed ID: 6979322
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of congenitally immunologically mutant New Zealand mice. VII: the ontogeny of thymic abnormalities and reconstitution of nude NZB/W mice.
    Gershwin ME; Castles JJ; Saito W; Ahmed A
    J Immunol; 1982 Nov; 129(5):2150-5. PubMed ID: 6749985
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymic microenvironmental abnormalities and thymic selection in NZB.H-2bm12 mice.
    Watanabe Y; Naiki M; Wilson T; Godfrey D; Chiang BL; Boyd R; Ansari A; Gershwin ME
    J Immunol; 1993 May; 150(10):4702-12. PubMed ID: 8097760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The failure to transfer the NZB disease following implantation of NZB thymus-containing chambers.
    Tuffrey M; Kingman J; Barnes RD
    Eur J Immunol; 1973 Aug; 3(8):519-21. PubMed ID: 4585315
    [No Abstract]   [Full Text] [Related]  

  • 9. Age-dependent changes of the levels of suppressor and helper T cells in New Zealand black mice.
    Imai Y; Oguchi Y; Nakano T; Osawa T
    Jpn J Exp Med; 1980 Dec; 50(6):415-21. PubMed ID: 6456367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic function in NZB mice. II. Regulatory influence of a circulating thymic factor on antibody production against polyvinylpyrrolidone in NZB mice.
    Bach MA; Niaudet P
    J Immunol; 1976 Sep; 117(3):760-4. PubMed ID: 1085309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response in NZB mice of different ages to thymus-dependent and thymus-independent phosphorylcholine antigens.
    McKearn JP; Miller GW; Quintáns J
    Immunology; 1978 Jun; 34(6):1063-9. PubMed ID: 355119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperactive T-cell function in young NZB mice; increased proliferative responses to allogenic cells.
    Palmer DW; Dauphinée MJ; Murphy E; Talal N
    Clin Exp Immunol; 1976 Mar; 23(3):578-81. PubMed ID: 133009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue localization and biochemical characteristics of a new thymic antigen recognized by a monoclonal thymocytotoxic autoantibody from New Zealand black mice.
    Bray KR; Gershwin ME; Ahmed A; Castles JJ
    J Immunol; 1985 Jun; 134(6):4001-8. PubMed ID: 3921616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective improvement of thymus and some T cell dysfunctions in NZB mice by in utero thymulin treatment.
    Quéré P; Dardenne M; Bach MA
    J Immunol; 1985 Aug; 135(2):1180-5. PubMed ID: 2409141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic correlations between brain and thymus. I. Common antigenic structures in rat and mouse brain tissue and thymocytes.
    Thiele HG; Stark R; Keeser D
    Eur J Immunol; 1972 Oct; 2(5):424-9. PubMed ID: 4538915
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic abnormality in NZB/W F1 mice. Thymus-independent expansion of B cells responding to interleukin-6.
    Mihara M; Fukui H; Koishihara Y; Saito M; Ohsugi Y
    Clin Exp Immunol; 1990 Dec; 82(3):533-7. PubMed ID: 2265491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofluorescence studies on thymocytotoxic antibody from New Zealand Black mice.
    Parker LM; Chused TM; Steinberg AD
    J Immunol; 1974 Jan; 112(1):285-92. PubMed ID: 4590823
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for an abnormal microenvironment in the thymus of New Zealand black mice.
    Dauphinée MJ; Palmer DW; Talal N
    J Immunol; 1975 Oct; 115(4):1054-9. PubMed ID: 1100721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-decrease of cells sensitive to an autoantibody-specific for thymocytes and thymus-dependent lymphocytes in NZB mice.
    Shirai T; Yoshiki T; Mellors RC
    Clin Exp Immunol; 1972 Dec; 12(4):455-64. PubMed ID: 4539827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cytotoxic effect of natural thymocytotoxic autoantibody of NZB mice on functional subsets of T cells.
    Shirai T; Hayakawa K; Okumura K; Tada T
    J Immunol; 1978 Jun; 120(6):1924-9. PubMed ID: 77882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.